跳到正文
cccskills
免费在 GitHub 公开

endo-annual-reassess-cgm-smbg-calibrate

Reassesses annually the patient’s use of self-monitoring blood glucose to calibrate the CGM system. Triggered by ‘Yearly calibration practice review’ or ‘Annual check of SMBG calibration adherence’.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL

实测评分 未实测

查看安装方法

包含的文件（1）

  • SKILL.md2.6 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Annually reassess use of SMBG to calibrate CGM

STEP 1 — Gather Information

Collect SMBG calibration frequency and timing, calibration log entries, sensor accuracy alerts, hypoglycemia/hyperglycemia events, patient-reported barriers (vision, dexterity, cognition), insurance coverage for strips, and current CGM model calibration requirements.

STEP 2 — Rule In / Rule Out

Is the patient performing SMBG calibration at least once per day (or per manufacturer’s recommendation) for the CGM system?

  • Yes → Rule In: adequate calibration practice.
  • No → Rule Out: inadequate calibration practice.

STEP 3 — Classify or Stratify

If Rule In: assess ability to make insulin adjustments based on CGM trend information (trend‑based dosing competence).
If Rule Out: classify barriers into cognitive/physical, insurance/access, or knowledge/behavioral deficits.

STEP 4 — Decide

  • If Rule In and trend‑based dosing competent: continue current CGM use with annual reassessment.
  • If Rule In but trend‑based dosing deficient: provide targeted education on interpreting CGM trends and adjusting insulin.
  • If Rule Out: address specific barriers (e.g., simplify SMBG routine, assist with strip access, consider factory‑calibrated CGM if appropriate, reinforce calibration training).

Clinical Guardrails / Mimics / Pitfalls

Do not assume calibration adequacy without reviewing logs; do not rely solely on CGM for therapy decisions on devices requiring calibration; do not discontinue SMBG without confirming the CGM is factory‑calibrated; do not overlook sensor site irritation that may deter SMBG; avoid alarm fatigue by ensuring alerts are appropriately set.

Concrete Clinical Example

A 58‑year‑old with T1D using a Dexcom G6 (requires calibration) presents for yearly review. Log shows SMBG calibration twice weekly, missing daily calibrations. Patient reports finger‑stick pain and forgetfulness. After Rule Out, barriers classified as behavioral/physical. Decision: switch to a factory‑calibrated CGM (Freestyle Libre 3) and provide brief SMBG refresher for occasional confirmation.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2534

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题